Back to the list
Congress: ECR25
Poster Number: C-14461
Type: Poster: EPOS Radiologist (educational)
Authorblock: M. Hovsepian, J. San Roman, C. Collaud, G. B. Amorin, N. Pabstleben; Buenos Aires/AR
Disclosures:
Magali Hovsepian: Nothing to disclose
Jose San Roman: Nothing to disclose
Carlos Collaud: Nothing to disclose
Gabriela Beatriz Amorin: Nothing to disclose
Nadia Pabstleben: Nothing to disclose
Keywords: Hybrid Imaging, Molecular imaging, Neuroradiology brain, PET-CT, Molecular imaging, Dementia, Motility
References
  1. Nevein Ibrahim, Joanna Kusmirek, Aaron F Struck, John M Floberg, Scott B Perlman, Catherine Gallagher, Lance T Hall. The sensitivity and specificity of F-DOPA PET in a movement disorder clinic. Am J Nucl Med Mol Imaging 2016;6(1):102-109.
  2. Silvia Morbelli, Giuseppe Esposito, Javier Arbizu, Henryk Barthel, Ronald Boellaard, Nico I. Bohnen, David J Brooks, Jacques Darcourt, John C. Dickson, David Douglas, Alexander Drzezga, Jacob Dubroff, Ozgul Ekmekcioglu, Valentina Garibotto, Peter Herscovitch, Phillip Kuo, Adriaan Lammertsma, Sabina Pappata, Iván Peñuelas, John Seibyl, Franck Semah, Livia Tossici-Bolt, Elsmarieke Van de Giessen, Koen Van Laere, Andrea Varrone, Michele Wanner, George Zubal, Ian Law. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. European Journal of Nuclear Medicine and Molecular Imaging (2020) 47:1885–1912.
  3. Sotirios Chondrogiannisa , Maria Cristina Marzolaa , Adil Al-Nahhasd , Thirumalesha D. Venkatanarayanad , Alberto Mazzab , Giuseppe Opocherc and Domenico Rubelloa. Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging. Nuclear Medicine Communications 2013, 34:1141–1149.
  4. Frédérique Depierreux, Eric Parmentier, Laurane Mackels, Katherine Baquero, Christian Degueldre, Evelyne Balteau, Eric Salmon, Christophe Phillips, Mohamed Ali Bahri, Pierre Maquet and Gaëtan Garraux. Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. npj Parkinson’s Disease (2021) 7:57.
  5. Alex Iep, Mohammad B. Chawki, Lucas Goldfarb, Loc Nguyen, Vincent Brulon, Claude Comtat, Vincent Lebon and Florent L. Besson. Relevance of 18F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study. EJNMMI Research (2023) 13:13.
  6. Biju G, de la Fuente-Fernandez R. Dopaminergic function and progression of Parkinson’s disease: PET findings. Parkinsonism Related Disorders. 2009;15(Suppl 4): S38–40. 
GALLERY